Age at onset in two common neurodegenerative diseases is genetically controlled.
about
Identification of risk and age-at-onset genes on chromosome 1p in Parkinson disease.High-resolution whole-genome association study of Parkinson disease.Genetics of Parkinson diseaseAssociation studies of 22 candidate SNPs with late-onset Alzheimer's diseaseThe sepiapterin reductase gene region reveals association in the PARK3 locus: analysis of familial and sporadic Parkinson's disease in European populationsInsulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivoGenetic of Alzheimer's Disease: A Narrative Review ArticlePARK10 is a major locus for sporadic neuropathologically confirmed Parkinson diseaseNovel Folding and Stability Defects Cause a Deficiency of Human Glutathione Transferase Omega 1Structural Insights into Omega-Class Glutathione Transferases: A Snapshot of Enzyme Reduction and Identification of a Non-Catalytic Ligandin SiteSystems biology of neurodegenerative diseasesAlzheimer's disease and environmental exposure to lead: the epidemiologic evidence and potential role of epigeneticsGenome-wide scan linkage analysis for Parkinson's disease: the European genetic study of Parkinson's diseaseParkinson disease loci in the mid-western AmishExpanded high-resolution genetic study of 109 Swedish families with Alzheimer's diseaseGenome-wide association analysis of age-at-onset in Alzheimer's diseaseGenomewide association study for onset age in Parkinson disease.Genomic variants, genes, and pathways of Alzheimer's disease: An overview.Replication study of genome-wide associated SNPs with late-onset Alzheimer's diseaseThe CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study.Replication of association between ELAVL4 and Parkinson disease: the GenePD study.Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association studyEvidence for three loci modifying age-at-onset of Alzheimer's disease in early-onset PSEN2 families.Genome scan in familial late-onset Alzheimer's disease: a locus on chromosome 6 contributes to age-at-onsetAssociation mapping of the PARK10 region for Parkinson's disease susceptibility genesApplication of a rank-based genetic association test to age-at-onset data from the Collaborative Study on the Genetics of Alcoholism study.Alzheimer's disease risk genes and the age-at-onset phenotype.Genomic susceptibility Loci for brain atrophy, ventricular volume, and leukoaraiosis in hypertensive sibshipsFine mapping of the alpha-T catenin gene to a quantitative trait locus on chromosome 10 in late-onset Alzheimer's disease pedigrees.Genome-wide scan for copy number variation association with age at onset of Alzheimer's disease.Ordered-subsets linkage analysis detects novel Alzheimer disease loci on chromosomes 2q34 and 15q22.Age-related macular degeneration--a genome scan in extended families.The PARK8 locus in autosomal dominant parkinsonism: confirmation of linkage and further delineation of the disease-containing interval.Disorder-specific effects of polymorphisms at opposing ends of the Insulin Degrading Enzyme gene.The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE.The omega-class glutathione transferases: structure, function, and genetics.Modeling amyloid beta-peptide insertion into lipid bilayersFine-mapping and candidate gene investigation within the PARK10 locus.A PIN1 polymorphism that prevents its suppression by AP4 associates with delayed onset of Alzheimer's disease.Exploratory data from complete genomes of familial alzheimer disease age-at-onset outliers.
P2860
Q24531223-C3D71965-328C-48B9-B2C1-0C1233348CCCQ24535861-104DB479-B11E-44AA-8B29-65D47685810FQ24558967-58D42DEA-8391-4A35-B180-CC1C8C7F5B4AQ24647572-D9154721-2960-4199-95B5-FF4A02343D61Q24651395-78E807E8-1C73-48AD-A8F2-37D5E58DE270Q24683214-6FDCBDD1-0428-4FA2-907A-CCA53C110068Q27007467-35005796-C646-4890-9E41-1BF14415D485Q27349225-07F3B974-E471-46D1-A03E-83C641680F2BQ27666060-F5527884-3377-4739-B02C-2A2033EAC204Q27677424-50A7D1A7-E244-462F-8B9D-3AC3CA5539AEQ28080741-7F00ACE2-0AC1-44B9-BA0D-5F52843DE3FEQ28394199-8E85D5CD-BFD2-4A0F-9E43-2FC5719C477AQ28764371-4450663F-0CED-48E0-950A-CA69A56BB008Q28943294-1E90B1A8-4856-4696-8BD1-BD2EE5322981Q29301019-61020EB4-E74B-4DA2-9938-C254E72D997EQ29417033-9BDB94C6-96F7-4AEF-8DD6-B489D9ED7E8CQ29417034-E98D5F67-82C6-4190-B06A-BC7AF9FCE7CEQ30240093-AB31A90C-39BD-4937-BC40-13D8E41C47D5Q30426556-DEC0DC8F-CB5E-4ADE-95A0-CEB88FF1DD4DQ30433658-B2096B27-89AE-4A3A-89CE-3F3D0F72EDF8Q30439050-29125C28-1EA8-4627-8523-636F172F9CE9Q30459046-9062E962-D9C1-4756-BCC1-184141F37044Q30497920-E9E4F8CD-6839-4850-A386-6CD044538CB5Q30539808-C5CA2285-F780-4796-BF9D-277F9FF8149FQ30573676-A2867378-AE36-4C25-AC0C-0558946BB918Q31031554-AA3C25CC-0751-459C-9D81-3B22D09CADBBQ33685232-4BD093C6-C886-4D13-A828-2EDE0C08027EQ33689539-E0140C42-2022-4EE2-BE8A-A7B452335499Q33719301-6697EBBA-2C60-42CB-A84F-3426E33F717EQ33790333-6E366B3E-F0A8-4C80-B5EE-35BC672746A5Q33905584-08D6458A-3630-4467-AA2C-E211D282990DQ33906317-9EFB5A82-7AE2-4949-BAFD-A5B10E5E1AE7Q33909482-BFB762C5-FCF8-41E4-A9F8-703B6665C163Q34080209-BD1D9D3A-8150-4EF9-AF70-2D6503D09DC6Q34123651-C810D7B8-95E9-4EBC-BF98-444A2FE893AEQ34178562-3D368274-BA97-4E73-9618-22D0977ABC56Q34185973-A59E1783-A251-4897-BDE7-D15DA5D96BCBQ34325867-7DB21AA6-38FB-4629-8CCA-429B065FEFF4Q34336304-161A5491-5778-4D02-A0EC-BAF491661DBAQ34350733-92F4207C-4D69-4A1A-8887-9AB909602F32
P2860
Age at onset in two common neurodegenerative diseases is genetically controlled.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2002
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Age at onset in two common neurodegenerative diseases is genetically controlled.
@en
Age at onset in two common neurodegenerative diseases is genetically controlled.
@nl
type
label
Age at onset in two common neurodegenerative diseases is genetically controlled.
@en
Age at onset in two common neurodegenerative diseases is genetically controlled.
@nl
prefLabel
Age at onset in two common neurodegenerative diseases is genetically controlled.
@en
Age at onset in two common neurodegenerative diseases is genetically controlled.
@nl
P2093
P2860
P50
P356
P1476
Age at onset in two common neurodegenerative diseases is genetically controlled.
@en
P2093
Allen D Roses
Allison D Reed
Ann M Saunders
Bradley C Hiner
Burton L Scott
Dale J Hedges
Donald E Schmechel
Fengyu Zhang
Frank Mastaglia
Fred A Allen
P2860
P304
P356
10.1086/339815
P407
P50
P577
2002-03-01T00:00:00Z